Directs the Food and Drug Administration to establish maximum cannabinoid content limits for hemp-derived consumable products with “fallback” limits in case the FDA does not act within 12 months after passage;
Will require federal limits on cannabinoid content for hemp-derived consumable products, with fallback limits if the FDA does not act within 12 months after passage.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
GovInfo lists H.R. 9830 as introduced by Andy Barr on July 22, 2026 and referred to House committees, with bill version "Introduced in House (IH)" and last action date July 22, 2026.
legacy_unverified · Source version not recorded · locator unknown
Section 425(b) would require the Secretary within 12 months after enactment to establish maximum cannabinoid-content amounts for hemp-derived cannabinoid products, and provides fallback total-THC limits if those amounts are not established in time.
Assessments
Barr introduced H.R. 9830 on July 22, 2026, and the bill text appears to match the promise by directing federal cannabinoid-content limits for hemp-derived consumable products with fallback limits if the agency does not act within 12 months. However, as of September 1, 2026, the measure remains introduced/referred in House committees and has not been enacted, so the promised federal requirement is not yet in force. This is a material same-term legislative effort, but delivery remains pending.